Cryosite Limited

As of June 30, 2026, Cryosite Limited carries a market capitalization of 61.01M, placing it among publicly traded companies globally. Its enterprise value stands at 66.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Cryosite Limited has 48.81M shares outstanding.

As of June 30, 2026, Cryosite Limited trades at a trailing price-to-earnings ratio of 27.30. The price-to-sales ratio is 3.65, and the price-to-book ratio stands at 12.58.

As of June 30, 2026, Cryosite Limited trades at an EV/EBITDA multiple of 16.33 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.98 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 21.04 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 66.49M versus a market cap of 61.01M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Cryosite Limited maintains a current ratio of 1.32, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 159.13, indicating elevated leverage, while an interest coverage ratio of 18.85 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Cryosite Limited posted a return on equity (ROE) of 61.75, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 25.34 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.84, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 27.73, useful for judging operating efficiency across full business cycles. The company generates approximately 618,518.52 in revenue per employee across its workforce of 27.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 125.50 indicates how many times Cryosite Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Cryosite Limited recorded 919,000.00 in income tax expense. That works out to an effective tax rate of 29.14, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.15M, leaving 2.24M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 20, 2026, Cryosite Limited's stock has gained approximately 23.65% over the past 52 weeks. The 50-day moving average sits at 1.15, while the 200-day moving average is 0.96.

Over the twelve months ended June 30, 2026, Cryosite Limited generated 16.70M in revenue and converted that into 2.24M in net income, yielding earnings per share of 0.04. EBITDA reached 4.07M, while operating income came in at 3.16M.

As of June 30, 2026, Cryosite Limited holds 2.24M in cash and equivalents against 7.72M in total debt, resulting in a net debt position of 3.41M. Total book value stands at 4.85M, with working capital of 1.52M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Cryosite Limited posted a gross margin of 62.43, reflecting its pricing power and cost economics. The operating margin of 18.92 and net profit margin of 13.38 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -8.38, meaning Cryosite Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Cryosite Limited's most recent stock split took place on April 29, 2004 with a 33:35 split ratio.

As of June 30, 2026, Cryosite Limited has an Altman Z-Score of 2.91, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.